| ［1］ |
Karpouzis A, Giatromanolaki A, Sivridis E, et al. Acquired reactive perforating collagenosis: current status［J］. J Dermatol, 2010,37（7）:585⁃592. doi: 10.1111/j.1346⁃8138.2010.00918.x.
|
| ［2］ |
Fei C, Wang Y, Gong Y, et al. Acquired reactive perforating collagenosis: a report of a typical case［J］. Medicine （Baltimore）, 2016,95（30）:e4305. doi: 10.1097/MD.0000000000004305.
|
| ［3］ |
Wang C, Liu YH, Wang YX, et al. Acquired reactive perforating collagenosis［J］. Chin Med J （Engl）, 2020,133（17）:2119⁃2120. doi: 10.1097/CM9.0000000000000906.
|
| ［4］ |
Hu QJ, Chen JJ, Yao Xu. Systematic review and meta⁃analysis literature⁃based clinical retrospective analysis of acquired reactive perforating collagenosis［J］. Int J Dermatol Venerol,2023:10.1097/JD9.0000000000000336. doi: 10.1097/JD9.0000000000000336.
|
| ［5］ |
Akoglu G, Emre S, Sungu N, et al. Clinicopathological features of 25 patients with acquired perforating dermatosis［J］. Eur J Dermatol, 2013,23（6）:864⁃871. doi: 10.1684/ejd.2013.2237.
|
| ［6］ |
祖丽克热, 李慧, 丁媛, 等. 抗桥粒芯糖蛋白1抗体阳性的获得性反应性穿通性胶原病1例［J］. 中华皮肤科杂志, 2023,56（10）:963-964. doi:10.35541/cjd.20210322.
|
| ［7］ |
Khalil NY, Darwish IA, Al⁃Qahtani AA. Isotretinoin［J］. Profiles Drug Subst Excip Relat Methodol, 2020,45:119⁃157. doi: 10.1016/bs.podrm.2019.10.005.
|
